- A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I) Effects of prophylactic paracetamol on immunogenicity and reactogenicity of routine infant vaccines and 4CMenB2014 | Publikace bez příslušnosti k fakultě
- Meningococcal serogroup B vaccine (4CMenB): Booster dose in previously vaccinated infants and primary vaccination in toddlers and two-year-old children2015 | Publikace bez příslušnosti k fakultě
- A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine, 4CMenB, in infants (II) Effects of variations of the OMV and protein content on immunogenicity and reactogenicity2014 | Publikace bez příslušnosti k fakultě
- Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials2013 | Publikace bez příslušnosti k fakultě
- Persistence of hSBA titers elicited by the meningococcal serogroup B vaccine menB-FHbp for up to 4 years after a 2-or 3-dose primary series and immunogenicity, safety, and tolerability of a booster dose through 26 months2021 | Publikace bez příslušnosti k fakultě
- Analýza očkování vakcínami proti meningokokovým onemocněním u pacientů s invazivním meningokokovým onemocněním, Česká republika, 2006-20222023 | 1. lékařská fakulta, Ústřední knihovna
- Immunogenicity and Tolerability of Recombinant Serogroup B Meningococcal Vaccine Administered With or Wtihout Routine Infant Vaccinations According to Different Immunization Schedules A Randomized Controlled Trial2012 | Publikace bez příslušnosti k fakultě
- Immunogenicity and safety of the quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in splenectomized or hyposplenic children and adolescents: Results of a phase III, open, non-randomized study2018 | Lékařská fakulta v Hradci Králové